Improve Outcomes with Diverse Datasets

Scalable and secure data collection, annotation, and chatbot translation services.

Get AI Now
Translations Memory Life Sci

Deploy high-performance AI products to improve patients’ quality of life

Life sciences organizations continue to amass enormous amounts of unstructured data sets. The complexity of these vast collections of data can prevent sponsors and other clinical companies from accessing operational and patient efficiencies offered by machine learning.

TransPerfect Life Sciences' AI/ML data services resolve the complexity and enable machine learning models by converting unstructured data to structured data, combining highly efficient human input with state-of-the-art tools and workflows so that the result is accurate and unbiased.

HIPAA-Compliant Data Collection and Annotation Built for Scale

Ensure better-balanced datasets across 200+ languages with our data collection and annotation services, without breaking the bank. Our labeling team is comprised of ground truth experts, meaning all data provided comes by direct observation/measurement. From audio to video and images to text, our platform provides a scalable content moderation solution in secure facilities on the cloud.

Chatbot Localization

An estimated 80% of standard queries can be answered by chatbots. Our end-to-end chatbot localization service ensures your stakeholders receive accurate, fast responses in their native language through collecting global patient prompts; categorizing said prompts into groups; and then running user tests for compliance, conceptual equivalence, and cultural appropriateness.

Learn More ›

The Latest Developments in Artificial Intelligence for Life Sciences

Benefits of our AI Platform, DataForce

  • Stronger, global, diverse datasets
  • Recruiting large volumes of resources at scale
  • Up to 80% reduction in timelines
  • Flexible integration capabilities with our platform or third party of your choice
  • Up to 1,000 annotators onboarded within weeks of project kick-off
  • Compliant with SSAE 16 SOC 2, ISO 27001, HIPAA, & GDPR

Enhance Internal Efficiencies While Improving Patients' Quality of Life

For data scientists, machine learning engineers, and product managers looking to deploy high-performance AI products in the healthcare industry, DataForce by TransPerfect is a market leader in scalable and secure data collection and annotation services. DataForce converts unstructured data to structured data, combining highly efficient human input with state-of-the-art tools and workflows so that the result is accurate and unbiased to ensure companies are at the front line of innovation in bringing treatments and solutions to the world.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Achieve Better Data and Smarter AI Today.

Schedule a Free Consult.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Thought Leadership

Our subject-matter experts have in-depth understanding of the technological challenges, requirements, and goals for life sciences organizations.

AI and Medical Device Regulations: Why Human Experts Still Sign Off

In our previous post, we covered the EUDAMED deadline for SSCPs and SSPs, which came up again and again at the RAPS Convergence Conference in Charlotte, North Carolina. In this post, we’re diving into another theme that was just as hard to miss: what AI means for the people who do regulatory work. That was the subject of an overflow session titled “How Is AI Affecting the Regulatory Workforce?” The question behind most of the discussion: Will AI take our jobs? The ...

AI and Medical Device Regulations: Why Human Experts Still Sign Off

How to Select the Right Regulatory Writing Company for Your Organization's Needs

In a landscape defined by ever-evolving global guidelines from health authorities, many life sciences organizations’ clinical and regulatory teams face challenges in navigating the regulatory affairs writing and document submission process. Adhering to strict rules while...

LifeSci Talks COA Series | Clinical Trial Site Burden: Why One Study Can Mean Up to 15 Systems

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Kees van Ooik, Vice President of Clinical Technologies at Almac Clinical Technologies, to talk about the burden clinical trial sites face when one study runs on up to ...

Governing AI for Global Content in the Life Sciences Industry

AI is already shaping the content that reaches patients, healthcare professionals, and regulators, often through tools that were never built for regulated use. But adoption alone doesn’t create control, and a single terminology error or untraceable approval can put compliance and ...

MDR SSCPs and IVDR SSPs Are NOT Labeling: What That Means for Your EUDAMED Upload

As soon as possible, but no later than March 27, 2027 (per MDCG 2026-4), medical device manufacturers must upload their validated, translated Summaries of Safety and Clinical Performance (SSCPs) to EUDAMED themselves. IVD manufacturers have the same responsibility for their...

Reddit Stories: AI Failures in Clinical Trials

Clinical operations experts react to real AI failure stories pulled directly from Reddit and work backward to identify what should have caught them. From hallucinated citations that passed an initial review to AI-drafted guidance sent to a site without proper oversight, each ...

Are Legacy COA Instruments Still Fit for Purpose?

The following insights are synthesized from TransPerfect LifeSci Talks, hosted by Mark P. Wade, Practice Leader COA SME at TransPerfect Life Sciences, with guest Kathrin Fischer, PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and board member of ISOQOL....